Purdue Pill May Force Zogenix’s Rival Drug Off Market

Purdue Pharma LP plans to apply for regulatory approval of a tamper-resistant competitor to Zogenix Inc.’s powerful pain pill, a move that could get its rival’s drug pulled from the market by U.S. regulators.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.